136. Deputy Dara Calleary asked the Minister for Public Expenditure and Reform the requirements his Department has placed on the Department of Health or the Health Service Executive to either notify it or seek its approval for expenditure on a new medicine or medicines; the date from which it has applied; the instances of such requirement being met; the criteria applied by his Department in responding to the Department of Health and or the Health Service Executive; and the policy justification for maintaining such requirement in view of the agreement entered into by the State with an organisation (details supplied). [41924/17]

Summary

136. Deputy Dara Calleary asked the Minister for Public Expenditure and Reform the requirements his Department has placed on the Department of Health or the Health Service Executive to either notify it or seek its approval for expenditure on a new medicine or medicines; the date from which it has applied; the instances of such requirement being met; the criteria applied by his Department in responding to the Department of Health and or the Health Service Executive; and the policy justification for maintaining such requirement in view of the agreement entered into by the State with an organisation (details supplied). [41924/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Expenditure

  xml · EN · 3 October 2017

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.